Lung Cancer Archives - SafeGenericPharmacy-MY HEALTH PARTNER

Cart:

0 item(s) - $0.00
You have no items in your shopping cart.

0

OFEV® (nintedanib) Now Available in the United States

OFEV® (nintedanib) Now Available in the United States

Boehringer Ingelheim launches comprehensive support resources for people with idiopathic pulmonary fibrosis RIDGEFIELD, Conn., October 20, 2014 – Boehringer Ingelheim Pharmaceuticals, Inc. has announced that OFEV® (nintedanib) capsules are now commercially available in the United States. OFEV was approved by the U.S. Food and Drug Administration (FDA) on October 15, 2014 for the treatment of idiopathic pulmonary fibrosis (IPF). It is the only kinase inhibitor approved to treat IPF. IPF is a rare and fatal lung disease that affects as many as 132,000…

Lung Cancer

Lung Cancer

Overview   For many years, lung cancer was considered a man’s disease. The reality, however, is that lung cancer is the most common cancer-related cause of death among men and women. In 1987, lung cancer surpassed breast cancer to become the leading cause of cancer death among U.S. women. In 2012, there will be an estimated 226,160 new cases of lung cancer accounting for about 14 percent of all cancers: an estimated 116,470 cases will be diagnosed in men and…